These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30179586)

  • 1. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update.
    Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X
    Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
    Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR
    Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing.
    Brewitz L; Tumber A; Schofield CJ
    J Biol Chem; 2020 Jun; 295(23):7826-7838. PubMed ID: 32107312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
    Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
    Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
    Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
    Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review).
    Zheng W; Wang X; Hu J; Bai B; Zhu H
    Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.
    Zou Q; Hou Y; Wang H; Wang K; Xing X; Xia Y; Wan X; Li J; Jiao B; Liu J; Huang A; Wu D; Xiang H; Pawlik TM; Wang H; Lau WY; Wang Y; Shen F
    EBioMedicine; 2018 May; 31():287-298. PubMed ID: 29764768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
    Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N
    Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern.
    Pfeffer I; Brewitz L; Krojer T; Jensen SA; Kochan GT; Kershaw NJ; Hewitson KS; McNeill LA; Kramer H; Münzel M; Hopkinson RJ; Oppermann U; Handford PA; McDonough MA; Schofield CJ
    Nat Commun; 2019 Oct; 10(1):4910. PubMed ID: 31659163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.
    Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR
    Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
    Zhang Y; Gao Y; Li Y; Zhang X; Xie H
    Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The distribution and expression pro-files of Aspartyl/Asparaginyl beta-hydroxylase (ASPH) in some tumorous cell lines and tissues].
    Song K; Xue XP; Wang W; Huyan T; Wang H; Yang H; Xie Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):141-4. PubMed ID: 20230674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype.
    Dong X; Lin Q; Aihara A; Li Y; Huang CK; Chung W; Tang Q; Chen X; Carlson R; Nadolny C; Gabriel G; Olsen M; Wands JR
    Oncotarget; 2015 Jan; 6(2):1231-48. PubMed ID: 25483102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK
    Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
    Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
    PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for production and assaying catalysis of isolated recombinant human aspartate/asparagine-β-hydroxylase.
    Brewitz L; Brasnett A; Schnaubelt LI; Rabe P; Tumber A; Schofield CJ
    Methods Enzymol; 2024; 704():313-344. PubMed ID: 39300654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of aspartate beta-hydroxylase in early breast cancer.
    Barboro P; Rubagotti A; Poddine S; Grillo F; Mastracci L; Boccardo F
    Int J Biol Markers; 2022 Sep; 37(3):328-335. PubMed ID: 35726161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartate β-hydroxylase as a target for cancer therapy.
    Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R
    J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.